GEXVAL
GEXVal is to help patients and families fighting against orphan and intractable diseases
GEXVAL
Industry:
Emergency Medicine Health Care
Founded:
2018-02-01
Address:
Fujisawa, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.gexval.com
Total Employee:
1+
Status:
Active
Total Funding:
1.11 B JPY
Current Advisors List
Current Employees Featured
Founder
Investors List
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series B - GEXVal
eBEST
eBEST investment in Series B - GEXVal
Yokohama Capital
Yokohama Capital investment in Series B - GEXVal
TNP Threads Of Light
TNP Threads Of Light investment in Series B - GEXVal
Shiratori Pharmaceuticals
Shiratori Pharmaceuticals investment in Series B - GEXVal
Healthcare Innovation
Healthcare Innovation investment in Series B - GEXVal
TNP Threads Of Light
TNP Threads Of Light investment in Series A - GEXVal
Takeda
Takeda investment in Series A - GEXVal
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series A - GEXVal
SMBC Venture Capital
SMBC Venture Capital investment in Series A - GEXVal
Official Site Inspections
http://www.gexval.com
- Host name: www19.gmoserver.jp
- IP address: 133.130.64.128
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo

More informations about "GEXVal"
GEXVal
Oct 3, 2024 Our goal is to help patients and families fighting against orphan and intractable diseasesSee details»
GEXVal
Oct 3, 2024 GEXVal Participates in BIO-EUROPE ® 2024 2024/10/29 GEXVal Selected as Finalist for CITELINE JAPAN AWARDS 2024 in Categories: EXECUTIVE OF THE YEAR & FINANCING DEAL OF THE YEAR 2024/10/8 โฆSee details»
Our company - GEXVal
The acronym GEXVal was devised as a shortened form of Generate Extra Value, which refers to the process of identifying such promising compounds and nurturing new value through โฆSee details»
Gexval - Crunchbase Company Profile & Funding
GEXVal is a research and development-oriented drug discovery company. The company specializes in the creation of treatments for rare and incurable diseases. The mission of GEXVal is to provide patients and families with the rare and โฆSee details»
GexVal Company Profile 2024: Valuation, Funding & Investors
GexVal General Information Description. Developer of a drug designed to focus on orphan and intractable diseases. The company develops compounds for the treatment of rare diseases in โฆSee details»
GEXVal Inc. - AEA
Nov 7, 2023 GEXVal, a Japan-based clinical-stage biopharma founded as a Takeda Pharmaceutical spin-off, tackles โAccess to Medicineโ issues in rare diseases and โฆSee details»
GEXVAL INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GEXVAL INC. of FUJISAWA, KANAGAWA. Get the latest business insights from Dun & Bradstreet.See details»
GEXVal Inc. - AEA
GEXVal, a Japan-based clinical-stage biopharma founded as a Takeda Pharmaceutical spin-off, tackles โAccess to Medicineโ issues in rare diseases and underserved medical conditions. As โฆSee details»
GEXVal - Company Profile - Tracxn
Oct 11, 2024 GEXVal - Developer of small molecule based therapeutics for the treatment of orphan and intractable diseases. Raised a total funding of $3.06M over 2 rounds from 6 โฆSee details»
GEXVal - Products, Competitors, Financials, Employees, โฆ
GEXVal. Frequently Asked Questions (FAQ) When was GEXVal founded? GEXVal was founded in 2018. Where is GEXVal's headquarters? GEXVal's headquarters is located at 2-26-1 โฆSee details»
Gexval - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Dec 4, 2023: Series C - Gexval . 5: ¥450M โ Sep โฆSee details»
GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets
Emerging Company Profile: Japanese company GEXVal is one of several bioventures formed from the spin-out of researchers and assets from Takeda, and is focused on bringing therapies โฆSee details»
Gexval - Contacts, Employees, Board Members, Advisors & Alumni โฆ
Organization. Gexval . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board โฆSee details»
To investors - GEXVal
To Investors, GEXVal is a pharma spin-out drug discovery startup based in Japan.. Our mission is to G enerate Ex tra Val ue to deliver cost-effective treatment to improve health and QoL of โฆSee details»
Gexval, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Gexval, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, Unknown, โฆSee details»
GEXVal Inc - VentureRadar
" GEXVal is a pharma spin-out drug discovery startup based in Japan. Our mission is to Generate Extra Value to deliver cost-effective treatment to improve health and QoL of patients and โฆSee details»
GEXVal Completed the Close of New Funding Round with JPY 450 โฆ
GEXVal Inc. 4 December 2023. GEXVal Completed the Close of New Funding Round with JPY 450 Million (USD 3 Million) GEXVal Inc. (President & CEO: Juran Kato, Kanagawa, Japan), a โฆSee details»
GEXVal is Listed in JETRO Japan Startup Market Map
Apr 21, 2023 We are pleased to announce that GEXVal Inc. is listed in the Japan startup market map launched by JETRO (Japan External Trade Organization). This is a map collection that โฆSee details»
Gexval - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of Gexval includes 2 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Gexval has โฆSee details»
GEXVal Inc. Announces Collaboration with FRAXA-DVI
GEXVal Inc. February 28, 2023. GEXVal Inc. is pleased to announce that we have initiated a collaboration project with FRAXA *-DVI ** (FRAXA-Drug Validation Initiative) ... FRAXA โฆSee details»